These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30901507)

  • 1. Anti-doping analytes in serum: A comparison of SST and SST-II Advance blood collection tubes.
    Miller GD; Cox HD; Nair V; Eichner D
    Drug Test Anal; 2019 Jul; 11(7):931-936. PubMed ID: 30901507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of decision limits for the GH-2000 detection methodology using additional insulin-like growth factor-I and amino-terminal pro-peptide of type III collagen assays.
    Holt RI; Böhning W; Guha N; Bartlett C; Cowan DA; Giraud S; Bassett EE; Sönksen PH; Böhning D
    Drug Test Anal; 2015 Sep; 7(9):745-55. PubMed ID: 25645199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker detection of rhGH doping: an excretion study.
    Jing J; Zhou X; He C; Zhang L; Yang S; Xu Y; Xie M; Yan Y; Su H; Wu M
    Drug Test Anal; 2012 Oct; 4(10):739-44. PubMed ID: 23074170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a freeze-thaw cycle and pre-analytical storage temperature on the stability of insulin-like growth factor-I and pro-collagen type III N-terminal propeptide concentrations: Implications for the detection of growth hormone misuse in athletes.
    Guha N; Erotokritou-Mulligan I; Bartlett C; Cowan DA; Bassett EE; Stow M; Sönksen PH; Holt RI
    Drug Test Anal; 2012 Jun; 4(6):455-9. PubMed ID: 22511534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracking growth hormone abuse in sport: performance of marker proteins in a controlled setting.
    Bosch J; Such-Sanmartín G; Segura J; Gutiérrez-Gallego R
    Anal Chim Acta; 2012 Oct; 745():118-23. PubMed ID: 22938615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunoassays for the measurement of insulin-like growth factor-I and procollagen type III peptide, indirect biomarkers of recombinant human growth hormone misuse in sport.
    Abellan R; Ventura R; Pichini S; Pascual JA; Pacifici R; Di Carlo S; Bacosi A; Segura J; Zuccaro P
    Clin Chem Lab Med; 2005; 43(1):75-85. PubMed ID: 15653447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Athlete Biological Passport Approach to the Detection of Growth Hormone Doping.
    Equey T; Pastor A; de la Torre Fornell R; Thomas A; Giraud S; Thevis M; Kuuranne T; Baume N; Barroso O; Aikin R
    J Clin Endocrinol Metab; 2022 Feb; 107(3):649-659. PubMed ID: 34726230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential parameters for the detection of hGH doping.
    Kniess A; Ziegler E; Kratzsch J; Thieme D; Müller RK
    Anal Bioanal Chem; 2003 Jul; 376(5):696-700. PubMed ID: 12750868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procollagen type III amino-terminal propeptide and insulin-like growth factor I as biomarkers of growth hormone administration.
    Cowan DA; Moncrieffe DA
    Drug Test Anal; 2022 May; 14(5):808-819. PubMed ID: 34418311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-individual variation of GH-dependent markers in athletes: comparison of population based and individual thresholds for detection of GH abuse in sports.
    Kniess A; Ziegler E; Thieme D; Müller RK
    J Pharm Biomed Anal; 2013 Oct; 84():201-8. PubMed ID: 23850935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the BD Vacutainer PST II blood collection tube for special chemistry analytes.
    Chance J; Berube J; Vandersmissen M; Blanckaert N
    Clin Chem Lab Med; 2009; 47(3):358-61. PubMed ID: 19676149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined evaluation of resting IGF-I, N-terminal propeptide of type III procollagen (PIIINP) and C-terminal cross-linked telopeptide of type I collagen (ICTP) levels might be useful for detecting inappropriate GH administration in athletes: a preliminary report.
    Sartorio A; Agosti F; Marazzi N; Maffiuletti NA; Cella SG; Rigamonti AE; Guidetti L; Di Luigi L; Muller EE
    Clin Endocrinol (Oxf); 2004 Oct; 61(4):487-93. PubMed ID: 15473882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers.
    Lehtihet M; Bhuiyan H; Dalby A; Ericsson M; Ekström L
    Drug Test Anal; 2019 Mar; 11(3):411-421. PubMed ID: 30223291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes.
    Di Luigi L; Rigamonti AE; Agosti F; Mencarelli M; Sgrò P; Marazzi N; Cella SG; Müller EE; Sartorio A
    Eur J Endocrinol; 2009 May; 160(5):753-8. PubMed ID: 19258430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the BD Vacutainer(®) RST blood collection tube for routine chemistry analytes: clinical significance of differences and stability study.
    Kocijancic M; Cargonja J; Delic-Knezevic A
    Biochem Med (Zagreb); 2014; 24(3):368-75. PubMed ID: 25351355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of BD Vacutainer SST Plus Tubes with BD SST II Plus Tubes for common analytes.
    Bush VJ; Janu MR; Bathur F; Wells A; Dasgupta A
    Clin Chim Acta; 2001 Apr; 306(1-2):139-43. PubMed ID: 11282105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of insulin-like growth factor-I misuse in athletes: the response of serum IGF-I, procollagen type III amino-terminal propeptide, and the GH-2000 score to the administration of rhIGF-I/rhIGF binding protein-3 complex.
    Guha N; Erotokritou-Mulligan I; Bartlett C; Nevitt SP; Francis M; Bassett EE; Cowan DA; Sönksen PH; Holt RI
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2259-68. PubMed ID: 24606087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting growth hormone abuse in athletes.
    Bidlingmaier M; Manolopoulou J
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):25-32, vii. PubMed ID: 20122447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of BD Vacutainer SST™ II Plus tubes for common tumor marker tests by Roche Diagnostics Modular E 170 analyzer.
    Li Z; Feng Z; Yan C; Yan R
    J Clin Lab Anal; 2010; 24(6):418-21. PubMed ID: 21089174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the analytic performance of blood collection tubes (BD Vacutainer SST) for the screening of anti-HIV, anti-HTLV, anti-HCV, anti-HBc, anti-CMV antibodies, and of HBs, P24 HIV antigens, and of alanine aminotransferase].
    Gobin E; Desruelle JM; Vigier JP
    Transfus Clin Biol; 2001 Feb; 8(1):44-50. PubMed ID: 11281063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.